[go: up one dir, main page]

PE20080286A1 - Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca - Google Patents

Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca

Info

Publication number
PE20080286A1
PE20080286A1 PE2007000956A PE2007000956A PE20080286A1 PE 20080286 A1 PE20080286 A1 PE 20080286A1 PE 2007000956 A PE2007000956 A PE 2007000956A PE 2007000956 A PE2007000956 A PE 2007000956A PE 20080286 A1 PE20080286 A1 PE 20080286A1
Authority
PE
Peru
Prior art keywords
nopal
cactus
reduce
composition including
superoxide dismutase
Prior art date
Application number
PE2007000956A
Other languages
English (en)
Inventor
Victor Hugo Diaz
Original Assignee
Victor Hugo Diaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victor Hugo Diaz filed Critical Victor Hugo Diaz
Publication of PE20080286A1 publication Critical patent/PE20080286A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: A) SUPEROXIDO DISMUTASA EN UNA CANTIDAD DE 50 A 300MG; B) CACTUS NOPAL EN UNA CANTIDAD DE 250 A 800MG; C) SESAMIN EN UNA CANTIDAD DE 250 A 500MG; D) ACIDO ALFA LIPOICO EN UNA CANTIDAD DE 50 A 300MG; Y E) OTROS COMPUESTOS TALES COMO TIAMINA, NIACINA, FOLATO, VITAMINA B12, ACIDO PANTOTENICO, EXTRACTO DE GINGO BILOBA, CAFEINA, ENTRE OTROS. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE LA RESACA INDUCIDA POR ALCOHOL
PE2007000956A 2006-07-24 2007-07-24 Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca PE20080286A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/493,480 US7879374B2 (en) 2005-07-22 2006-07-24 Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers

Publications (1)

Publication Number Publication Date
PE20080286A1 true PE20080286A1 (es) 2008-05-21

Family

ID=38971742

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000956A PE20080286A1 (es) 2006-07-24 2007-07-24 Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca

Country Status (5)

Country Link
US (1) US7879374B2 (es)
AR (1) AR062042A1 (es)
CL (1) CL2007001940A1 (es)
PE (1) PE20080286A1 (es)
WO (1) WO2008014256A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100209557A1 (en) * 2009-02-14 2010-08-19 O'connor Daniel C Recovery blends for liquid beverages
US20100316735A1 (en) * 2009-04-10 2010-12-16 Wade Belliston Compositions and methods for reducing hangover symptoms
US8377907B1 (en) 2011-02-21 2013-02-19 William A. Halamicek, III Compositions for treating alcohol hangover
US10251924B2 (en) * 2013-09-25 2019-04-09 Northern Innovations Holding Corp Compositions containing myristica fragrans
IT201700119556A1 (it) * 2017-10-23 2019-04-23 Glauco Isella Integratore alimentare energizzante e suo uso.
CA3012021A1 (en) * 2018-07-20 2020-01-20 Detoxicated Inc. Composition and method for the alleviation of effects of alcohol consumption
WO2020252051A1 (en) 2019-06-11 2020-12-17 Advance Pharmaceutical, Inc. Super-oxide dismutase soluble fiber compositions
CN114271490A (zh) * 2021-12-02 2022-04-05 深圳中科欣扬生物科技有限公司 一种含sod和麦角硫因的抗疲劳抗氧化和解酒功能的保健配方
US12285458B2 (en) * 2023-04-28 2025-04-29 Cheers Health, Inc. Compositions and methods for alleviating adverse effects from responsible alcohol consumption

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1379149A (en) * 1920-09-03 1921-05-24 John C Wichmann Process of making rubber-like material and resulting product
US2980587A (en) * 1955-03-21 1961-04-18 Philips Corp Dry stable vitamin a and/or d-preparation and methods of producing same
US4496548A (en) * 1983-02-04 1985-01-29 Moldowan Mervin J Composition and method for reducing hangover
GB8325627D0 (en) * 1983-09-24 1983-10-26 Scras Therapeutic compositions
US5538878A (en) * 1988-08-08 1996-07-23 Calgene, Inc. Superoxide dismutase expression in plants
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6228347B1 (en) 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
EP0960572A1 (en) * 1998-05-12 1999-12-01 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
US6229347B1 (en) * 1999-01-11 2001-05-08 United Microelectronics, Corp. Circuit for evaluating an asysmetric antenna effect
KR100318223B1 (ko) * 1999-07-05 2001-12-22 김찬식 페피노 추출물을 함유하는 혈중알콜농도 저하용 조성물 및 그 제조방법
US6485758B2 (en) * 2000-02-18 2002-11-26 Vasolabs, Inc. Hangover treatment
US6447820B1 (en) * 2001-01-22 2002-09-10 Sarfaraz K Niazi Pharmaceutical composition for the prevention and treatment of scar tissue
US6365198B1 (en) * 2001-01-28 2002-04-02 Gulf Pharmaceutical Industries Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids
JP2003070444A (ja) * 2001-06-19 2003-03-11 Kawakami Trading Inc 添加剤、食品、飲料、調味料及び化粧品
KR100523562B1 (ko) 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
US20040082667A1 (en) * 2002-10-16 2004-04-29 Mccadden Kenneth Hangover treatment
US7371413B2 (en) * 2003-05-05 2008-05-13 Rutgers, The State University Antioxidant and anti-inflammatory activity of compounds and preparations from African nutmeg seeds
US7956031B2 (en) * 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy

Also Published As

Publication number Publication date
WO2008014256A3 (en) 2008-12-11
CL2007001940A1 (es) 2008-02-29
WO2008014256A2 (en) 2008-01-31
AR062042A1 (es) 2008-08-10
US7879374B2 (en) 2011-02-01
US20080020071A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
PE20080286A1 (es) Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca
UY33241A (es) ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
CL2008001612A1 (es) 5-(3-hidroxi-7-sustituido-naftalen-2-il)-1, 1-dioxo-[1,2,5]tiadiazolidin-3-ona; su uso para tratar un trastorno hiperproliferativo; la composicion farmaceutica que los contiene; y sus procesos de preparacion.
CL2007001166A1 (es) Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica
UY32072A (es) Tienopirimidinas para composiciones farmacéuticas
CR20150174A (es) Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio
CL2013001982A1 (es) Metodo para reducir los niveles de glucosa y tratar trastornos del metabolismo de la misma; composicion farmaceutica que comprende metformina y otro agente antidiabetico o antiobesidad.
CL2012002317A1 (es) Compuestos derivados de tienopirimidinas, inhibitores de quinasas mnk1/mnk2; composicion farmaceutica; y su uso para elt ratamiento o profilaxis de enfermedades metabolicas, tales como diabetes, daño renal, cancer, enfermedades inflamatorias, entre otras.
ECSP13012661A (es) Composición farmacéutica, métodos de tratamiento y usos de la misma.
UY35472A (es) Compuestos y sus usos en la modulacion de la hemoglobina
BR112013020753A2 (pt) método para extrair corpos oleosos, corpos oleosos secos, composição, uso de corpos oleosos, gênero alimentício ou ingrediente, produto para cuidado pessoal, e, uso de um corpo oleoso seco
CO6382089A2 (es) Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias
AR053803A1 (es) Uso de acido pinolenico
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
GT201500035A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
GT200600200A (es) Composicion farmaceutica que contienen gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato
AR102780A1 (es) Composiciones farmacéuticas, su preparación y sus usos
MX2011012741A (es) Un suplemento que comprende grosellas negras o moras grandes.
CL2007001748A1 (es) Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras.
AR074454A1 (es) Compuestos 4-(-heterocicloalquil) benceno-1,3-diol como inhibidores de la tirosinasa, y su uso en medicina humana y tambien en cosmetica
CL2008003372A1 (es) Compuestos derivados de metil-bencimidazol, procedimiento de preparacion, composicion farmaceutica que los contiene y uso en el tratamiento y/o profilaxis de enfermedades afectadas por moduladores de fxr, en particular, dislipidemia, enfermedades de absorcion de colesterol y aterosclerosis, entre otras.
BR112014032583A2 (pt) forma farmacêutica para liberação prolongada de substâncias ativas
CL2011001777A1 (es) Composicion farmaceutica que contiene aleglitazar; proceso para preparar dicha composicion farmaceutica; y su uso para el tratamiento o profilaxis de la diabetes tipo ii o enfermedades cardiovasculares.
BR112015000179A2 (pt) terapia de combinação para o tratamento de câncer e imunossupressão

Legal Events

Date Code Title Description
FC Refusal